FATE THERAPEUTICS INC Deferred Tax Assets, Operating Loss Carryforwards, Foreign
FATE THERAPEUTICS INC (FATE) had Deferred Tax Assets, Operating Loss Carryforwards, Foreign of $36.00 thousand as of 2014-12-31, per its 10-K filed 2015-03-12.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign · last filed 2015-03-12
- 2014-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $36.00K.
- 2013-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $72.00K.
- 2012-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $101.00K.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Foreign |
|---|---|
| 2014-12-31 | $36.00K 10-K · filed 2015-03-12 |
| 2013-12-31 | $72.00K 10-K · filed 2015-03-12 |
| 2012-12-31 | $101.00K 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |